Calcium signaling in endocardial and epicardial ventricular myocytes from streptozotocin‐induced diabetic rats

Abstract

Aims/Introduction: Abnormalities in Ca2+ signaling have a key role in hemodynamic dysfunction in diabetic heart. The purpose of this study was to explore the effects of streptozotocin (STZ) - induced diabetes on Ca2+ signaling in epicardial (EPI) and endocardial (ENDO) cells of the left ventricle, after 5-6 months of STZ injection.
Materials and Methods: Whole-cell patch clamp was used to measure L-type Ca2+ channel (LTCC) and Na+/Ca2+ exchanger (NCX) currents. Fluorescence photometry techniques were used to measure intracellular free Ca2+ concentration [Ca2+]i. Results: Although LTCC current was not significantly altered, the amplitude (AMP) of Ca2+ transients increased significantly in EPI-STZ and ENDO-STZ compared to controls. Time to peak (TPK) LTCC current, TPK Ca2+ transient, time to half (THALF) decay of LTCC current and THALF decay of Ca2+ transients were not significantly changed in EPI-STZ and ENDO-STZ myocytes compared to controls. NCX current was significantly smaller in EPI-STZ and in ENDO-STZ compared to controls. Conclusions: STZ-induced diabetes resulted in an increase in AMP of Ca2+ transients in EPI and ENDO myocyte that was independent of LTCC current. Such an effect can be attributed, at least in part, to the dysfunction of NCX. Additional studies are warranted to improve our understanding of the regional impact of diabetes on Ca2+ signaling, which will facilitate the discovery of new targeted treatments for diabetic cardiomyopathy.